Abstract
Background
It has been reported recently that PP2, a Src family kinase inhibitor, promotes selective
cardiogenesis in embryonic stem cells. However, there is no other research proved
pro-cardiogenic characteristic of PP2 so far. In this study, we explored the potential
cardiogenic effect of PP2 on P19 cells differentiation.
Methods
P19-αMHC-EGFP cell line was established by transfecting P19 cells with αMHC-EGFP vector
in order to evaluate cardiogenesis with EGFP. P19-αMHC-EGFP cells and P19 cells were
induced to differentiate into cardiomyocytes with 1%DMSO, 5 μmol/L PP2, or both 1%DMSO and 5 μmol/L PP2. Differentiated cells from P19-αMHC-EGFP cells were then assessed under
confocal microscope. Western-blot and RT-PCR were also performed to detect expression
of cardiac troponin I and cardiac transcription factors respectively. In addition,
the effects of PP2 on proliferation of P19 cells were further examined using Cell
Counting Kit-8.
Results
EGFP positive cells were firstly detected on day 7 and PP2 alone cannot induce efficient
cardiac differentiation of P19-αMHC-EGFP cells. However PP2 supplementation dramatically
increases DMSO induced cardiac differentiation than DMSO alone. It was also found
that PP2 inhibit proliferation of P19 cells in both a dose-dependent manner and a
time-dependent manner.
Conclusion
PP2 alone cannot substitute DMSO to induce cardiac differentiation, however, PP2 supplementation
drastically promotes DMSO-induced cardiac differentiation of P19 cells. The increased
percentages of differentiated cardiac myocytes is partly resulting from cell proliferative
inhibit effect of PP2 in undifferentiated P19 cells. P19-αMHC-EGFP cell line has the
potential to be used for regenerative therapies in experimental models of heart repair.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to International Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Isolation of male embryonal carcinoma cells and their chromosome replication patterns.Dev Bio. 1982; 89: 503-508
- P19 embryonal carcinoma cells.Int J Dev Biol. 1993; 37: 135-140
- Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.J Biol Chem. 2000; 275: 41-46
- Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line.Nature. 1982; 299: 165-167
- 5-azacytidine induces cardiac differentiation of P19 embryonic stem cells.Exp Mol Med. 2004; 36: 515-523
- Cardiac differentiation of P19CL6 cells by oxytocin.Int J Cardiol. 2009; 134: 75-81
- Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes.Proc Natl Acad Sci USA. 2002; 99: 9550-9555
- The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line.Dev Biol. 1983; 98: 187-191
- Skeletal and cardiac myogenesis accompany adipogenesis in P19 embryonal stem cells.Stem Cells Dev. 2009; 18: 1023-1032
- Small molecules that induce cardiomyogenesis in embryonic stem cells.J Am Chem Soc. 2004; 126: 1590-1591
- Focal adhesion kinase signaling regulates cardiogenesis of embryonic stem cells.J Biol Chem. 2005; 280: 39534-39544
- Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173.Mol Cell Biochem. 2011; 348: 11-19
- Src family kinases play multiple roles in differentiation of trophoblasts from human term placenta.J Physiol. 2006; 571: 537-553
- Le bellego F, Lafond J. PP2 regulates human trophoblast cells differentiation by activating p38 and ERK1/2 and inhibiting FAK activation.Placenta. 2008; 29: 862-870
- Identification and characterization of embryonic stem cell-derived pacemaker and atrial cardiomyocytes.FASEB J. 2005; 19: 577-579
- Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes.J Biol Chem. 2004; 279: 11384-11391
- Induction of cardiogenesis in embryonic stem cells via downregulation of Notch1 signaling.Circ Res. 2006; 98: 1471-1478
- Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro.Exp Biol Med (Maywood). 2004; 229: 623-631
- In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells.Biochem Biophys Res Commun. 2006; 340: 639-647
- Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation.Cardiovasc Res. 2003; 58: 292-302
- Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes.Circulation. 2003; 107: 1912-1916
- Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells.J Biol Chem. 1998; 273: 34904-34910
- GATA-4 promotes the differentiation of P19 cells into cardiac myocytes.Int J Mol Med. 2011; 26: 365-372
- BMP induction of cardiogenesis in P19 cells requires prior cell-cell interaction(s).Dev Dyn. 2006; 235: 2122-2133
- Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4.Mol Cell Biol. 1999; 19: 7096-7105
- Enhanced cardiomyogenic differentiation of p19 embryonal carcinoma stem cells.Korean Circ J. 2009; 39: 198-204
Article info
Publication history
Published online: May 10, 2012
Accepted:
April 8,
2012
Received in revised form:
February 21,
2012
Received:
October 1,
2011
Footnotes
☆Project supported by the National Natural Science Foundation of China (No. 30900630), the Natural Science Foundation of Jiangsu Province (No. BK2009209).
Identification
Copyright
© 2012 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.
